Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1726281

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1726281

UK Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceutical), By Animal Type (Production, Companion), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

UK Veterinary Medicine Market Growth & Trends:

The UK veterinary medicine market size is anticipated to reach USD 4.08 billion by 2030 and is anticipated to grow at a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the novel product development in veterinary medicine, the rise in livestock population and increasing pet ownership rates, and the increasing government initiatives to spread awareness about animal health.

There is an increasing trend of pet adoption in the country, particularly influenced by the increasing ownership of smaller pets. According to the UK Pet Food 2024 stats, the pet dog population is estimated to be around 13.5 million, which accounts for around 36% of the households in the country owning a dog. Similarly, the pet cat population is estimated to be around 12.5 million, which accounts for around 29% of the households in the country owning a cat. This surge in pet ownership has led to greater consumer spending on veterinary medicines as pet owners are increasingly prioritizing their pets' health, resulting in higher expenditures on veterinary care, medications, and preventive treatments. As pet owners become more aware of the long-term health implications and necessary care for their pets, the demand for veterinary medicine in the country is further anticipated to increase.

In addition, the increasing efforts by government and private bodies through various partnerships and initiatives to increase awareness about animal health among pet and cattle owners are further contributing to the market growth. For instance, The Animal Health and Welfare Pathway, launched in 2023, aims to enhance farm animal health and welfare in the UK through collaboration among farmers, veterinarians, and the industry. This initiative is part of the Agricultural Transition Plan, focusing on improving biosecurity, tackling antimicrobial resistance, and reducing greenhouse gas emissions from livestock.

Financial support for farmers is one of the major focuses of the pathway, offering funding for veterinary consultations, capital investments, and disease control programs. This includes grants for infrastructure improvements and initiatives to enhance stockmanship through training. The pathway also aims to stimulate market demand for higher welfare products by improving transparency and ensuring fair pricing for farmers.

Moreover, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention due to their potential impact on public health. This awareness drives pet owners and livestock farmers to seek preventive care and vaccinations for their animals, thereby boosting the demand for veterinary medication. Similarly, in agriculture, changing practices aimed at improving animal welfare and productivity are driving demand for veterinary interventions as farmers are increasingly adopting biosecurity measures to prevent disease outbreaks within livestock populations, thereby contributing to segment growth.

UK Veterinary Medicine Market Report Highlights:

  • The pharmaceutical segment accounted for the largest revenue share of 67.5% in 2024 due to its wide range of clinically approved drugs that effectively treat and prevent various animal diseases.
  • The production animal segment dominated the market with the largest revenue share of over 58% in 2024, as livestock health is directly tied to food safety, productivity, and economic returns for farmers.
  • The injectables segment dominated the market, with a revenue share of over 44% in 2024 due to their rapid action, high bioavailability, and effectiveness in treating a wide range of conditions.
  • The veterinary hospitals and clinics segment dominated the market with the largest share of over 40% in 2024.
Product Code: GVR-4-68040-422-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Animal Type Segment
    • 1.2.3. Route of Administration Segment
    • 1.2.4. Distribution Channel Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. UK Veterinary Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in livestock population and increasing pet ownership rates
      • 3.2.1.2. Novel product development in veterinary medicine
      • 3.2.1.3. Increasing prevalence of animal diseases
      • 3.2.1.4. Strategic initiatives by key players
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory Challenges
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. UK Veterinary Medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
  • 3.4. Estimated Animal Population by Key Species, 2018 - 2024
  • 3.5. Regulatory Framework
  • 3.6. Product Pipeline Analysis
  • 3.7. Pricing Analysis

Chapter 4. UK Veterinary Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. UK Veterinary Medicine Market Product Movement Analysis
  • 4.3. UK Veterinary Medicine Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
  • 4.4. Biologics
    • 4.4.1. Biologics market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Vaccines
      • 4.4.2.1. Vaccines market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.2. Modified/ Attenuated live
        • 4.4.2.2.1. Modified/ Attenuated live market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.3. Inactivated
        • 4.4.2.3.1. Inactivated market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.4. Other vaccines
        • 4.4.2.4.1. Other vaccines market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Other biologics
      • 4.4.3.1. Other biologics market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Pharmaceuticals
    • 4.5.1. Pharmaceuticals market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.2. Parasiticides
      • 4.5.2.1. Parasiticides market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.3. Anti-infectives
      • 4.5.3.1. Anti-infectives market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.4. Anti-inflammatory
      • 4.5.4.1. Anti-inflammatory market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.5. Analgesics
      • 4.5.5.1. Analgesics market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Medicated feed additives
    • 4.6.1. Medicated feed additives market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. UK Veterinary Medicine Market: Animal Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. UK Veterinary Medicine Market Animal Type Movement Analysis
  • 5.3. UK Veterinary Medicine Market Size & Trend Analysis, by Animal Type, 2018 - 2030 (USD Million)
  • 5.4. Production animals
    • 5.4.1. Production animals market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.4.2. Poultry
      • 5.4.2.1. Poultry market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.4.3. Pigs
      • 5.4.3.1. Pigs market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.4.4. Cattle
      • 5.4.4.1. Cattle market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.4.5. Sheep & goats
      • 5.4.5.1. Sheep & goats market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Companion animals
    • 5.5.1. Companion animals market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.2. Dogs
      • 5.5.2.1. Dogs market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.3. Cats
      • 5.5.3.1. Cats market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.4. Horses
      • 5.5.4.1. Horses market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. UK Veterinary Medicine Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. UK Veterinary Medicine Market Route of Administration Movement Analysis
  • 6.3. UK Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2018 - 2030 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Injectable market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Topical
    • 6.6.1. Topical market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Other routes
    • 6.7.1. Other routes market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. UK Veterinary Medicine Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. UK Veterinary Medicine Market Distribution Channel Movement Analysis
  • 7.3. UK Veterinary Medicine Market Size & Trend Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
  • 7.4. Veterinary hospitals & clinics
    • 7.4.1. Veterinary hospitals & clinics market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. E-commerce market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Offline retail stores
    • 7.6.1. Offline retail stores market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Boehringer Ingelheim International GmbH.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Norbrook
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merck & Co., Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Elanco
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Bimeda, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Zoetis UK Limited.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Ceva
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. BioZyme, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Phibro Animal Health Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Dechra (EQT)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
Product Code: GVR-4-68040-422-7

List of Tables

  • Table 1 List of abbreviation
  • Table 2 UK Veterinary medicine market, by product, 2018 - 2030 (USD Million)
  • Table 3 UK Veterinary medicine market, by animal type, 2018 - 2030 (USD Million)
  • Table 4 UK Veterinary medicine market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 UK Veterinary medicine market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 Company Overview
  • Table 7 Product Benchmarking
  • Table 8 Financial Performance
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 UK veterinary medicine market: Market outlook
  • Fig. 5 UK veterinary medicine market: Segment outlook
  • Fig. 6 UK veterinary medicine market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 UK veterinary medicine market driver impact
  • Fig. 9 UK veterinary medicine market restraint impact
  • Fig. 10 UK veterinary medicine market: Product outlook and key takeaways
  • Fig. 11 UK veterinary medicine market: Product movement analysis
  • Fig. 12 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Modified/ Attenuated live market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Inactivated market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Other vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Other biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Parasiticides market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Anti-infectives market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Anti-inflammatory market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Analgesics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Medicated feed additives market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 UK veterinary medicine market: Animal Type outlook and key takeaways
  • Fig. 26 UK veterinary medicine market: Animal Type movement analysis
  • Fig. 27 Production animals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Poultry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Pigs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cattle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Sheep & goats market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Companion animals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Dogs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cats market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Horses market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK veterinary medicine market: Route of Administration outlook and key takeaways
  • Fig. 39 UK veterinary medicine market: Route of Administration movement analysis
  • Fig. 40 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Topical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Other routes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK veterinary medicine market: Distribution Channel outlook and key takeaways
  • Fig. 45 UK veterinary medicine market: Distribution Channel movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Veterinary hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 E-commerce market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Offline retail stores market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!